ENTITY
Lupin Ltd

Lupin Ltd (LPC IN)

142
Analysis
Health CareIndia
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
more
Refresh
02 Nov 2023 06:55Broker

Axis Top Picks - ‘Growth at a Reasonable Price’ – an Overarching Theme - Nov 2023

We are proud to share that our Axis Top Picks basket delivered impressive returns of 25% in the last one year, beating the benchmark Nifty 50 index

Logo
206 Views
Share
12 Oct 2023 08:33Broker

Pharma - Q2FY24 - Earnings Preview

The Pharma companies under our coverage are likely to report aggregate Revenue/EBITDA/PAT growth of 17.4%/23.8%/25.2% YoY in Q2FY24E.

Logo
271 Views
Share
05 Oct 2023 07:59Broker

Axis Top Picks - Oct 2023

We are proud to share that our Axis Top Picks basket delivered impressive returns of 32% in the last one year, beating by a wide margin the 15%...

Logo
555 Views
Share
04 Sep 2023 23:52Broker

Axis Research Scorecard Report - August 2023

We are proud to share that we released several Top Sector Ideas during the month and we highly encourage you to refer to these exclusive reports

Logo
309 Views
Share
02 Sep 2023 08:51Broker

Axis Top Picks for the month of September 2023

Axis Top Picks basket delivered impressive returns of 28% in the last one year, against the 8% return posted by Nifty 50, beating the benchmark by...

Logo
403 Views
Share
x